Article Text

PDF
OP0023 Germinal and Somatic Genetic Variants of TNFAIP3 Promote Lymphomagenesis Process Complicating Primary Sjögren’s Syndrome
  1. G. Nocturne1,
  2. S. Boudaoud1,
  3. C. Miceli Richard2,
  4. S. Viengchareun3,
  5. T. Lazure4,
  6. J. Nititham5,
  7. K. E. Taylor5,
  8. L. A. Criswell5,
  9. A. Ma5,
  10. F. Busato6,
  11. J. Melki7,
  12. J. J. Dubost8,
  13. E. Hachulla9,
  14. J. E. Gottenberg10,
  15. M. Lombes3,
  16. J. Tost6,
  17. X. Mariette2
  1. 1INSERM U1012
  2. 2Hôpitaux Universitaires Paris-Sud
  3. 3INSERM U693
  4. 4AP-HP Hôpitaux Universitaires Paris-Sud, Le Kremlin Bicêtre, France
  5. 5University of California, San Francisco, United States
  6. 6CEA-Institut de Génomique, Evry
  7. 7UMR-788, Le Kremlin Bicêtre
  8. 8CHU Gahriel Montpied, Clermont Ferrand
  9. 9Hôpital Claude Huriez, Université de Lille 2, Lille
  10. 10EA 4438, Strasbourg University, Strasbourg, France

Abstract

Background The pathophysiology of lymphomas in auto immune disease (AID) involves persistent inflammation and activation of autoimmune B cells leading to NF-kB activation. The TNFAIP3 gene encodes the A20 protein, a central gatekeeper of NF-kB activation. Germinal abnormalities in TNFAIP3 have been associated with different AID and somatic mutations of the gene have been observed in several lymphoma subtypes, particularly MALT lymphoma, the lymphoma subtype most frequently associated with pSS.

Objectives To investigate whether TNFAIP3 abnormalities are involved in the lymphomagenesis process in pSS.

Methods The discovery set was constituted by 584 pSS patients including 25 patients with lymphoma and 451 controls of Caucasian ancestry, addressed by 48 Ancestry Informative Markers. Three SNPs encompassing the TNFAIP3 locus located on 6q23 (rs13192841, rs2230926 and rs6922466) and known to be associated with SLE and RA were genotyped. 19 additional patients with pSS and lymphoma were used for extension and replication. We sequenced all TNFAIP3 exons in germinal and lymphoma DNA from 20 pSS patients with lymphoma. Functional abnormalities of A20 were assessed by gene reporter assays.

Results The 3 TNFAIP3 SNPs were not significantly associated with risk of pSS. But multivariate analysis demonstrated a significant association between the rs2230926 SNP (coding for an amino acid substitution in exon 3) and pSS complicated by lymphoma: OR vs controls = 3.36 (95%CI 1.34 - 8.42) p= 0.0097, OR vs pSS without lymphoma = 3.26 [95%CI 1.31 – 8.12], p=0.011. TNFAIP3 gene sequencing of germinal DNA from 43 patients with pSS and lymphoma confirmed the more frequent presence of the rs2230926G risk variant in 11/43 patients (25.6%, versus 11% in controls, p=0.018). Twelve of the 20 (60%) patients with paired germinal and lymphoma TNFAIP3 sequence data had functional abnormalities of A20. The frequency was even higher (77%) among pSS patients with MALT lymphoma (n=28). Mutated A20 variants (rs2230926G and GG insertion) were both less effective than the wild type A20 in inhibiting NF-kB-dependent activation (p< 0.0001).

Conclusions This study demonstrates that A20 inactivation plays a key role in lymphomagenesis in the context of autoimmunity. It supports a scenario in which the presence of germinal and/or somatic abnormalities of genes leading to impaired control of NF-kB activation in B cells continuously stimulated by autoimmunity enhances the risk of lymphoma.

Disclosure of Interest None Declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.